ReviewClinical and translational science2018

Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.

Stephanie Faucette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.